Lidocaine Hydrochloride Noridem (Lidocaine Hydrochloride Monohydrate)

Lidocaine blocks voltage‑gated sodium channels on nerve membranes, stabilizing them in an inactive state. By preventing sodium influx, it stops the generation and propagation of action potentials, which interrupts the transmission of pain signals from the site of administration to the brain, resulting in localized loss of sensation.

The appropriate dose of Lidocaine Hydrochloride Noridem is determined by the prescribing clinician based on the specific procedure, patient age, weight, and health status. Dosage calculations consider the concentration of the solution, the route of administration, and any relevant safety limits to avoid toxicity.

Safety data for lidocaine use in pregnancy and lactation are limited. It should only be used when the potential benefit to the mother outweighs any possible risk to the fetus or infant. Clinicians are advised to discuss individual circumstances with the patient and consider alternative options when appropriate.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and necessary import documentation.

Lidocaine is an amide‑type local anesthetic with a rapid onset (1–3 minutes) and moderate duration (1–2 hours) for infiltration. Compared with bupivacaine, it has a shorter duration but a lower risk of cardiotoxicity. Compared with procaine (an ester), lidocaine offers faster onset and longer action, making it a common choice for many short‑procedural anesthetic needs.

Lidocaine Hydrochloride Noridem should be stored at ambient temperature, preferably below 25 °C. Keep the vial in its original packaging, protect it from moisture, direct sunlight and extreme temperature fluctuations. Do not freeze the solution, and inspect for particulate matter before use.

The product is supplied as a sterile solution for injection. It can be administered epidurally, by infiltration into soft tissue, or intradermally, depending on the clinical indication. Administration is performed by a qualified healthcare professional using aseptic technique and appropriate dosing guidelines.

Serious adverse events include systemic toxicity leading to central nervous system symptoms such as seizures, cardiac arrhythmias or cardiac arrest, severe allergic reactions (anaphylaxis), and rare cases of methemoglobinemia. Prompt recognition and supportive management are essential if these events occur.

Patients with a known hypersensitivity to lidocaine or other amide‑type local anesthetics, those with severe heart block, uncontrolled arrhythmias, or significant hepatic impairment should avoid this product. It is also contraindicated in patients with certain congenital cardiac conduction disorders unless specifically directed by a specialist.